Pfizer expects to roughly double the number of coronavirus vaccine doses it makes per week for use in the U.S, CEO Albert Bourla said Friday at an event with President Joe Biden held at the company's plant in Kalamazoo, Michigan.
The boost in production should take effect in the next "couple weeks," Bourla said, noting the drugmaker currently manufactures about 5 million doses each week.
Today, the U.S. Food and Drug Administration announced that it is allowing undiluted frozen vials of the Pfizer-BioNTech COVID-19 Vaccine to be transported and stored at conventional temperatures commonly found in pharmaceutical freezers for a period of up to two weeks.